|
|
|
Insider
Information: |
Kolchinsky Peter |
Relationship: |
Director, 10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
21 |
|
Direct
Shares |
6,648,738 |
|
Indirect Shares
|
89,615,900 |
|
|
Direct
Value |
$30,628,641 |
|
|
Indirect Value
|
$932,125,367 |
|
|
Total
Shares |
96,264,638 |
|
|
Total
Value |
$962,754,008 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
14.5%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Aradigm Corp |
ARDM |
10% Owner |
2007-03-01 |
0 |
2008-01-15 |
7,681,410 |
Premium* |
|
Curis Inc |
CRIS |
10% Owner |
2008-04-15 |
0 |
2008-04-15 |
6,250,564 |
Premium* |
|
Sequenom Inc |
SQNM |
10% Owner |
|
0 |
2008-06-06 |
4,617,766 |
Premium* |
|
Biospecifics Technologies Corp |
BSTC |
10% Owner |
2008-12-29 |
0 |
2009-04-14 |
825,844 |
Premium* |
|
Lipid Sciences Inc |
LIPD |
10% Owner |
2008-03-27 |
0 |
2008-03-27 |
3,705,312 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
2013-09-30 |
4,816,562 |
2014-09-11 |
13,000,000 |
Premium* |
|
Sangamo Biosciences Inc |
SGMO |
Former 10% Owner |
2014-08-01 |
1,829,426 |
2013-07-17 |
0 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2015-10-07 |
0 |
2015-10-21 |
2,314,942 |
Premium* |
|
Ra Pharmaceuticals, Inc. |
RARX |
Director, 10% Owner |
2016-10-31 |
0 |
2020-04-02 |
0 |
Premium* |
|
Kalvista Pharmaceuticals Inc |
KALV |
Director, 10% Owner |
2016-11-21 |
0 |
2017-10-12 |
1,441,070 |
Premium* |
|
G1 Therapeutics Inc |
GTHX |
Fmr 10% Owner See Foot... |
2017-05-22 |
0 |
2017-05-22 |
2,684,244 |
Premium* |
|
Kala Pharmaceuticals, Inc. |
KALA |
Director, 10% Owner |
2017-07-25 |
0 |
2020-03-13 |
10,874,613 |
Premium* |
|
Wave Life Sciences Ltd. |
WVE |
Director, 10% Owner |
2017-11-13 |
0 |
2019-01-24 |
7,775,207 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2017-12-18 |
0 |
2019-12-02 |
0 |
Premium* |
|
Eidos Therapeutics, Inc. |
EIDX |
10% Owner |
2018-06-22 |
0 |
2018-06-22 |
2,162,671 |
Premium* |
|
Arvinas Holding Company, Llc |
ARVN |
Former 10% Owner |
2018-10-01 |
0 |
2018-10-01 |
3,138,412 |
Premium* |
|
Synthorx, Inc. |
THOR |
Director, 10% Owner |
2018-12-11 |
0 |
2020-01-23 |
0 |
Premium* |
|
Satsuma Pharmaceuticals, Inc. |
STSA |
Former 10% Owner |
2019-09-17 |
0 |
2023-06-08 |
0 |
Premium* |
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
|
0 |
2019-10-16 |
5,422,312 |
Premium* |
|
Forma Therapeutics Holdings, Inc., |
FMTX |
Director, 10% Owner |
2021-06-17 |
2,750 |
2021-06-17 |
9,011,651 |
Premium* |
|
Solid Biosciences Inc |
SLDB |
Director, 10% Owner |
|
0 |
2020-12-10 |
8,709,882 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
207 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2013-09-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
11,657,061 |
|
- |
|
SGMO |
Sangamo Biosciences Inc |
10% Owner |
|
2013-12-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,028,362 |
|
- |
|
SGMO |
Sangamo Biosciences Inc |
10% Owner |
|
2014-01-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,683,002 |
|
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-08-25 |
4 |
S |
$10.94 |
$3,632,282 |
I/I |
(331,396) |
17,919,611 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-08-26 |
4 |
S |
$11.13 |
$23,981,551 |
I/I |
(2,112,867) |
15,806,744 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-08-27 |
4 |
S |
$11.48 |
$3,096,776 |
I/I |
(267,089) |
15,539,655 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-08-28 |
4 |
S |
$11.51 |
$1,999,372 |
I/I |
(173,641) |
15,366,014 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-08-29 |
4 |
S |
$11.40 |
$4,551,768 |
I/I |
(398,845) |
14,967,169 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-09-02 |
4 |
S |
$11.93 |
$3,160,329 |
I/I |
(262,807) |
14,704,362 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-09-10 |
4 |
S |
$12.61 |
$2,147,483,647 |
I/I |
(522,450) |
14,181,912 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2014-09-11 |
4 |
S |
$12.31 |
$14,605,225 |
I/I |
(1,181,912) |
13,000,000 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,237,130 |
|
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-07 |
4 |
B |
$10.66 |
$24,051,364 |
I/I |
2,215,439 |
2,215,439 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-08 |
4 |
B |
$11.00 |
$238,555 |
I/I |
21,691 |
2,237,130 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-14 |
4 |
B |
$14.06 |
$601,792 |
I/I |
42,813 |
2,279,943 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-19 |
4 |
B |
$14.88 |
$356,049 |
I/I |
23,934 |
2,303,877 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-20 |
4 |
B |
$14.95 |
$119,070 |
I/I |
7,965 |
2,311,842 |
1.5 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
10% Owner |
|
2015-10-21 |
4 |
B |
$14.83 |
$45,976 |
I/I |
3,100 |
2,314,942 |
1.5 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2016-10-31 |
4 |
A |
$0.00 |
$0 |
I/I |
1,190,270 |
1,190,270 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2016-10-31 |
4 |
B |
$13.00 |
$2,099,994 |
I/I |
161,538 |
1,351,808 |
1.5 |
- |
|
KALV |
Kalvista Pharmaceuticals ... |
10% Owner |
|
2016-11-21 |
4 |
A |
$0.00 |
$0 |
I/I |
591,070 |
591,070 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2018-02-14 |
4 |
B |
$6.00 |
$15,000,000 |
I/I |
2,500,000 |
3,851,808 |
1.5 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
|
2018-06-22 |
4 |
B |
$17.00 |
$18,000,008 |
I/I |
1,058,824 |
2,162,671 |
1.5 |
- |
|
EIDX |
Eidos Therapeutics, Inc. |
10% Owner |
|
2018-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,103,847 |
1,103,847 |
0 |
- |
|
STSA |
Satsuma Pharmaceuticals, ... |
10% Owner |
|
2019-09-17 |
4 |
B |
$15.00 |
$19,999,995 |
I/I |
1,333,333 |
4,681,858 |
1.5 |
- |
|
207 Records found
|
|
Page 3 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|